ICD-10-CM Billable Code

T38.3X4

Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, undetermined

Clinical Classification Guidelines

Medical Intelligence & Overview

Poisoning by insulin and oral hypoglycemic drugs, classified under ICD-10 code T38.3X4, refers to cases where individuals have experienced adverse effects or an overdose of medications used to manage diabetes. These medications include insulin injections and various oral drugs designed to lower blood sugar levels. While these drugs are essential for controlling diabetes, improper use, overdose, or accidental ingestion can lead to dangerous health complications. This guide provides a clear understanding of what this type of poisoning entails, its causes, symptoms, and general considerations associated with diagnosis and treatment.

Causes & Symptoms

Clinical Causes: Accidental overdose of insulin or oral hypoglycemic medications Misinterpretation of medication instructions Failure to adhere to prescribed dosage guidelines Intentional self-harm or suicide attempts involving overuse of diabetic medications Mixing up medications due to poor organization or unclear labeling Use of expired or contaminated medications

Key Symptoms: Hypoglycemia (low blood sugar): - Shaking or trembling - Sweating - Dizziness or lightheadedness - Heart palpitations - Hunger - Confusion or difficulty concentrating - Weakness or fatigue - Irritability Severe hypoglycemia symptoms: - Loss of consciousness - Seizures - Coma

Diagnostic & Treatment

Diagnosis Path: Diagnosis of poisoning by insulin and oral hypoglycemic drugs typically involves several steps. Healthcare providers will review the patient's medical history, including medication use and recent dosages. Blood tests are essential for confirming hypoglycemia and measuring blood sugar levels. Toxicology screens may be conducted to determine the presence and concentration of medications in the bloodstream. Additional assessments might include evaluating organ function and checking for other complications resulting from overdose. The diagnosis aims to identify the cause promptly to guide appropriate treatment strategies.

Treatment Protocols: Treatment for poisoning caused by insulin and oral hypoglycemic drugs focuses on rapidly restoring normal blood sugar levels and addressing the effects of overdose. Common interventions include: - Administration of glucose, either orally or intravenously, to counteract hypoglycemia - Monitoring blood glucose levels frequently to guide ongoing treatment - Supportive care to maintain vital signs - Management of seizures or unconsciousness if present - In cases of severe overdose, administration of specific antidotes or medications as deemed necessary by healthcare professionals - Counseling and education on medication management to prevent future incidents Follow-up care may involve adjusting medication doses, reviewing diabetes management plans, and providing patient education to prevent recurrence of poisoning effects.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T38.3X4 a billable ICD-10 code?
Yes, T38.3X4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T38.3X4?
Clinical documentation must specify the nature of Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, undetermined and any associated comorbidities for accurate reporting.

Cite this Clinical Reference